WinstonWınston
POMDOCTOR logo

POMDOCTOR

POM
Medical - Pharmaceuticals · Healthcare
Price
$1.13
-0.24 (-17.52%)
Market Cap
$7.7M
Exchange
NASDAQ Global Market
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+782.7% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 6.6M (2021) → 58.1M (2025)

I don't have reliable information about a company called POMDOCTOR Ltd trading under the ticker POM in the pharmaceuticals industry. This does not match any well-known public company in my knowledge base, and the financial profile provided (near-zero market cap, deeply negative operating margin, unusually high ROIC) suggests this may be a very small or obscure listing.

Rather than invent details about products, customers, or operations, I want to flag this honestly: producing a description with fabricated specifics could mislead investors.

If you can provide additional context — such as what country it is listed in, what drugs or services it offers, or a brief business description — I can write an accurate two-paragraph summary using that information.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

R&D Spend

$13M/ year

Rising (+329% vs prior year)

3.2% of revenue

Below sector average (18%)

R&D investment increasing — building for the future

Insider Activity

97.7%ownership

Insiders own a meaningful stake in the company

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
N/A
no trend
Data not available
Operating Margin
N/A
no trend
Data not available
ROCE
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
N/A
no trend
Data not available
EPS YoY
N/A
no trend
Data not available
EPS Consistency
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
no trend
Data not available
FCF Margin
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
no trend
Data not available
Interest Cover
N/A
no trend
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial